netFormulary NHS
Lancashire and South Cumbria
Formulary
 Search
 Formulary Chapter 13: Skin - Full Section
Notes:

Dermatology prescribing may require use of expensive unlicensed
creams and ointments (known as ‘Specials’). Please consult the revised British Association of Dermatologists (BAD) list of preferred Specials (2018) for advice on appropriate product choice.

Specials Recommended by the British Association of Dermatologists for Skin Disease

Several medicines in the skin chapter are available for purchase over the counter and may be appropriate for self care. Please consult the local OTC policy for more details.

LSCMMG: Over The Counter (OTC) Items That Should Not Be Routinely Prescribed In Primary Care Policy 
 Useful Links
Link   LSCMMG: Guidelines for the Management of Psoriasis in Primary Care
Link   LSCMMG: Position Statement: Prescribing of Medical Camouflaging Products
Link   LSCMMG: Psoriasis in adults: LSCMMG Biologic and High Cost Drug Commissioning Pathway
Link   NICE CG153: Psoriasis: assessment and management
Link   NICE CG57: Atopic eczema in under 12s: diagnosis and management
Link   NICE NG12: Suspected cancer: recognition and referral
Link   NICE NG14: Melanoma: assessment and management
Link   NICE NG198: Acne vulgaris: management
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
13.01 Management of skin conditions (2,0)
13.01.01 Vehicles (0,0)
13.01.02 Suitable quantities for prescribing (0,0)
13.01.03 Excipients and sensitisation (0,0)
13.02 Emollient and barrier preparations (0,0)
13.02.01 Emollients (6,0)
spacespace Emollients - with antimicrobials (1,0)
spacespace Preparations containing urea (3,0)
13.02.02 Barrier preparations (6,0)
13.03 Topical local anaesthetics and antipruritics (3,0)
13.04 Topical corticosteroids. (16,0)
spacespace Topical corticosteriod preparation potencies (0,0)
spacespace Topical corticosteroids (Potency: Mild) (0,0)
spacespace Topical corticosteroids (Potency: Moderate) (0,0)
spacespace Topical corticosteroids (Potency: Potent) (0,0)
spacespace Topical corticosteroids (Potency: Very Potent) (0,0)
spacespace Topical corticosteroids – Compound preparations – with antimicrobials (0,0)
spacespace Topical corticosteroids – Compound preparations – with salicyclic acid (0,0)
13.05.01 Preparations for eczema (3,0)
spacespace Topical preparations for eczema (0,0)
13.05.02 Preparations for psoriasis (4,0)
spacespace Topical preparations for psoriasis (7,0)
spacespace Oral retinoids for psoriasis (1,0)
13.05.03 Drugs affecting the immune response (27,0)
13.06 Acne and rosacea (2,0)
13.06.01 Topical preparations for acne (0,0)
spacespace Benzoyl peroxide and azelaic acid (3,0)
spacespace Topical antibacterials for acne (2,0)
spacespace Topical retinoids and related preparations for acne (4,0)
13.06.02 Oral preparations for acne (0,0)
spacespace Oral antibiotics for acne (4,0)
spacespace Hormone treatment for acne (1,0)
spacespace Oral retinoid for acne (1,0)
13.06.03 Topical preparations for rosacea (0,0)
13.07 Preparations for warts and calluses (3,0)
spacespace Anogenital warts (2,0)
13.08 Sunscreens and camouflagers (0,0)
13.08.01 Sunscreen preparations (2,0)
spacespace Photodamage (8,0)
13.08.02 Camouflagers (1,0)
13.09 Shampoos and other preparations for scalp and hair conditions (3,0)
spacespace Hirsutism (1,0)
13.10 Anti-infective skin preparations (0,0)
13.10.01 Antibacterial preparations (0,0)
13.10.01.01 Antibacterial preparations only used topically (2,0)
13.10.01.02 Antibacterial preparations also used systemically (2,0)
13.10.02 Antifungal preparations (3,0)
13.10.03 Antiviral preparations (1,0)
spacespace Scabies (0,0)
spacespace Crab lice (0,0)
spacespace Dimeticone (1,0)
spacespace Malathion (1,0)
spacespace Permethrin (1,0)
13.11 Skin cleansers, antiseptics, and desloughing agents (1,0)
13.11.02 Chlorhexidine salts (1,0)
13.11.06 Oxidisers, and dyes (2,0)
13.11.07 Desloughing agents (1,0)
spacespace Desloughing agents (0,0)
13.12 Antiperspirants (1,0)
13.14 dermatology specials (0,0)
netFormulary